Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease

The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…

Read More

From Executive Perk to Employee Retention Strategy: Why Concierge Medicine and/or Direct Primary Care Is Now a Business Essential

With staffing shortages, historic burnout, and rising costs, concierge medicine — and direct primary care (DPC) — have moved from the margins into the middle of the retention conversation. The post From Executive Perk to Employee Retention Strategy: Why Concierge Medicine and/or Direct Primary Care Is Now a Business Essential appeared first on MedCity News.

Read More